insights_auto
Why is EDIT down 2.41%?
Dive Deeperchevron_right
EDIT:NASDAQ
Editas Medicine Inc
$1.82
arrow_downward
-2.41%(-0.045) 1D
$1.82
0.00% (0.00)
bedtimeAfter hours
Closed: Nov 17, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
$1.90
High
$1.94
Low
$1.82
Mkt. cap
281.67M
Avg. vol.
2.41M
Volume
2.00M
52-wk high
$3.94
52-wk low
$1.66
EPS
-$0.62
Beta
2.09
Shares outstanding
154.34M
No. of employees
87
Open
$1.90
High
$1.94
Low
$1.82
Mkt. cap
281.67M
Avg. vol.
2.41M
Volume
2.00M
52-wk high
$3.94
52-wk low
$1.66
EPS
-$0.62
Beta
2.09
Shares outstanding
154.34M
No. of employees
87
News stories
From web sources and news partners
ChartMill
·
1 hour ago
S&P 500 Losers: Software Stocks Lead Session Declines
Fox Business
·
1 hour ago
S&P 500 decline driven by semiconductor confidence issues, says Scott Chronert
MarketWatch
·
1 hour ago
Only two ‘Magnificent Seven’ stocks have managed to beat the S&P 500 since the start of 2025
Traders Union
·
1 hour ago
Bitcoin-to-S&P 500 ratio holds trendline support, James Van Straten notes
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc
CEO-
Employees87
FoundedNov 2013
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteeditasmedicine.com